First quarter 2020 results presentation

Operating income, growth figures, profitability and how our products have behaved.


No votes yet
 
Related
ROVI REPORTS OPERATING REVENUE GROWTH OF 54% AND NET PROFIT GROWTH OF 151% Operating revenue increased by 54% to 648.7 million euros...
2 min
23/02/2022
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Laboratorios...
2 min
16/02/2022
Today, Laboratorios Farmacéuticos Rovi, S.A. (“ROVI” or the “Company”) has announced that the European Commission has authorised the...
3 min
15/02/2022